Liwagon, Jella Mae S.

HRN: 24-99-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2024
CEFUROXIME 750MG (VIAL)
05/19/2024
05/26/2024
IV
450mg
Q 8 Hours
AGE, UTI
Waiting Final Action 
05/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/20/2024
06/03/2024
IV
130mg
Q8
H. Pylori Infection
Waiting Final Action 
05/20/2024
CLARITHROMYCIN 250 MG/5ML
05/20/2024
06/03/2024
ORAL
2ml
Q12
H. Pylori Infection
Waiting Final Action 
05/21/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
05/21/2024
05/27/2024
ORAL
4ml
BID
Pcap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: